share_log

HC Wainwright & Co. Maintains Buy on Connect Biopharma Hldgs, Raises Price Target to $8

Benzinga ·  Apr 17 18:40

HC Wainwright & Co. analyst Emily Bodnar maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and raises the price target from $7 to $8.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment